PharmaNetics, manufacturer of a platform for point of care monitoring of whole blood coagulation.
PHARMANETICS CONTACTS
PHARMANETICS ANNOUNCES FIRST QUARTER RESULTS
PHARMANETICS ANNOUNCES YEAR END RESULTS
PharmaNetics - Y2K Solutions
PHARMANETICS RECEIVES FDA 510K CLEARANCE TO MARKET NEW
PHARMANETICS TO BROADCAST ITS SECOND QUARTER CONFERENCE CALL
PHARMANETICS ANNOUNCES SECOND QUARTER RESULTS
PHARMANETICS SIGNS AGREEMENT WITH THE MEDICINES COMPANY
PHARMANETICS COMPLETES ENROLLMENT OF 600-PATIENT ELECT TRIAL
PHARMANETICS ANNOUNCES RESULTS OF 600-PATIENT ELECT TRIAL
PHARMANETICS ANNOUNCES THIRD QUARTER RESULTS
PHARMANETICS TO BROADCAST ITS THIRD QUARTER CONFERENCE CALL
PHARMANETICS RECEIVES FINAL MILESTONE PAYMENT FROM AVENTIS
PHARMANETICS TO BROADCAST ITS FOURTH QUARTERAND YEAR-END
PHARMANETICS ANNOUNCES FILING OF 510 (K) APPLICATION FOR ITS
DATA PRESENTED AT AmSECT DEMONSTRATES SIGNIFICANT ADVANTAGES OF
PHARMANETICS ANNOUNCES FOURTH QUARTER AND YEAR-END RESULTS
About PharmaNetics - Annual Reports
PHARMANETICS ANNOUNCES COLLABORATIVE SALES AND MARKETING
PHARMANETICS RAISES OVER $9.5 MILLION IN PREFERRED STOCK
CASE HISTORY IN JOURNAL OF INVASIVE CARDIOLOGY DEMONSTRATES
PHARMANETICS TO BROADCAST ITS FIRST QUARTER CONFERENCE CALL
Raleigh, NC (April 30, 2003) – PharmaNetics, Inc
CASE SERIES IN JOURNAL OF INVASIVE CARDIOLOGY DESCRIBES THE
Raleigh, NC (July 21, 2003) – PharmaNetics, Inc
Raleigh, NC (July 31, 2003) – PharmaNetics, Inc
Raleigh, NC (November 4, 2003) – PharmaNetics, Inc
MEDIA CONTACT
PHARMANETICS SEEKS STRATEGIC ALTERNATIVES, INCLUDING SALE OF
THE JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY FAST TRACKS
PHARMANETICS ENGAGES FINANCIAL ADVISOR TO ASSIST IN REVIEW OF
PHARMANETICS ANNOUNCES DATE OF HEARING IN LAWSUIT AGAINST
Index of /pdfs/pi_languages
Index of /pdfs/pi_languages/eqc
Index of /pdfs/pi_languages/hmp12
Index of /pdfs/pi_languages/appt12
Index of /pdfs/pi_languages/hmt
Index of /pdfs/pi_languages/htt
Index of /pdfs/pi_languages/pt_nc
Index of /pdfs/pi_languages/lhmt12
Index of /pdfs/pi_languages/pt
Index of /pdfs/pi_languages/pt12
Index of /pdfs/pi_languages/lhmt
Index of /pdfs/pi_languages/prt
Index of /pdfs/pi_languages/hmt_c12
Index of /pdfs/pi_languages/pt_one
Index of /pdfs/pi_languages/pt_nc12
Index of /pdfs/pi_languages/aptt
PHARMANETICS EXPECTS DECISION ON CLAIM AGAINST AVENTIS BEFORE
PHARMANETICS STOCK TO BE TRADED ON THE OTC BULLETIN BOARD
PHARMANETICS DISCLOSES FILING OF FORM 10-K
Index of /pdfs
Index of /pdfs/inserts
Index of /pdfs/packageinserts
Index of /pdfs/pi
Litigation Review
Aboutanim
Existingprod
PharmaNetics - What's New - Products in Development or Regulatory Review
PharmaNetics
JOHN P. FUNKHOUSER
PharmaNetics - Job Opportunities
Request Information About PharmaNetics
PharmaNetics - Our Technology
PharmaNetics - Our Products
About PharmaNetics
PharmaNetics' Articles and Abstracts
PharmaNetics - ECT Test
PharmaNetics - ECT Test (German)
PharmaNetics - Under Development - Products in Development or Regulatory Review
PharmaNetics - Existing Products
PharmaNetics - Product Performance
Package Inserts available for download in PDF fornat
PharmaNetics - Who to Contact
About PharmaNetics : Press Releases
Directions From RDU International Airport:
PharmaNetics' Ecarin Clotting Time - Articles and Abstracts
Cardiovascular Diagnostics - Press Releases
About PharmaNetics : Press Releases : PHARMANETICS AND AVENTIS PHARMACEUTICALS ANNOUNCE FILING OF 510K APPLICATION FOR ENOXAPARIN TEST
About PharmaNetics : Press Releases : PHARMANETICS ANNOUNCES PLAN TO REPURCHASE SHARES OF ITS COMMON STOCK
About PharmaNetics : Press Releases : PHARMANETICS ANNOUNCES SECOND QUARTER RESULTS
About PharmaNetics : Press Releases : PHARMANETICS RECEIVES $1.5 MILLION PAYMENT FROM ASTRAZENECA
About PharmaNetics : Press Releases : COMPANY STRENGTHENS TECHNICAL RESOURCES IN SUPPORT OF THERANOSTIC STRATEGY
About PharmaNetics : Press Releases : PHARMANETICS ANNOUNCES FIRST QUARTER RESULTS
About PharmaNetics : Press Releases : BAYER INVESTS $17.4 MILLION IN PHARMANETICS; COMPANIES WILL DEVELOP FUTURE NEAR PATIENT TESTING PRODUCTS
About PharmaNetics : Press Releases : PHARMANETICS ANNOUNCES 2000 RESULTS Year End Results In Line With Company Estimates
About PharmaNetics : Press Releases : PHARMANETICS SIGNS EXCLUSIVE WORLDWIDE LICENSE WITH PAION GmbH FOR THE USE OF SOLULIN
About PharmaNetics : Press Releases : ™
About PharmaNetics : Press Releases : PHARMANETICS ANNOUNCES NEW CLINICAL STUDY WITH PROMINENT INVESTIGATION TEAM
About PharmaNetics : Press Releases : PHARMANETICS ANNOUNCES THIRD QUARTER RESULTS
About PharmaNetics : Press Releases : PHARMANETICS AND AVENTIS PHARMACEUTICALS SIGN EXCLUSIVE AGREEMENT FOR ENOXAPARIN TEST
About PharmaNetics : Press Releases : PHARMANETICS REPORTS SECOND QUARTER RESULTS
About PharmaNetics : Press Releases : PHARMANETICS COMPLETES FIELD TRIALS OF RAPID TEST TO MONITOR LOW MOLECULAR WEIGHT HEPARIN
About PharmaNetics : Press Releases : PHARMANETICS RECEIVES HUMANITARIAN DEVICE EXEMPTION FOR ECARIN CLOTTING TIME TEST TO MONITOR REFLUDAN
About PharmaNetics : Press Releases : PHARMANETICS REPORTS FIRST QUARTER RESULTS
About PharmaNetics : Press Releases : PHARMANETICS SIGNS AGREEMENT WITH AVENTIS PHARMACEUTICALS TO DEVELOP THERANOSTIC TEST FOR ENOXAPARIN
About PharmaNetics : Press Releases : BAYER DIAGNOSTICS AND PHARMANETICS ANNOUNCE 510(K) CLEARANCE FOR NEW LOW RANGE HEPARIN MANAGEMENT TEST (LHMT)
About PharmaNetics : Press Releases : PHARMANETICS TO INVESTIGATE NEW THERANOSTIC TESTS UTILIZING SCHERING'S SOLULIN
About PharmaNetics : Press Releases : PHARMANETICS INITIATES CLINICAL TESTING OF RAPID TEST TO MONITOR LOW MOLECULAR WEIGHT HEPARIN
About PharmaNetics : Press Releases : PHARMANETICS ACQUIRES EXCLUSIVE LICENSE TO PATENTS DESCRIBING METHODS OF DETERMINING PLATELET FUNCTION
About PharmaNetics : Press Releases : PHARMANETICS SINGLE USE CONTROLS CLEARED BY FDA COMPLETES REGULATORY CLEARANCE FOR RAPIDPOINT™ ACCENT™ SYSTEM
About PharmaNetics : Press Releases : BAYER CORPORATION SIGNS AGREEMENT WITH PHARMANETICS TO DEVELOP NEW PLATELET FUNCTION THERANOSTIC TEST
About PharmaNetics : Press Releases : PHARMANETICS REPORTS FOURTH QUARTER AND YEAR END RESULTS
About PharmaNetics : Press Releases : PHARMANETICS COMPLETES $12 MILLION PRIVATE PLACEMENT
About PharmaNetics : Press Releases : PHARMANETICS TO SEEK ADDITIONAL CAPITAL
About PharmaNetics : Press Releases : PHARMANETICS HEPARIN MANAGEMENT PANEL APPROVED BY FDA
About PharmaNetics : Press Releases : PHARMANETICS ANNOUNCES EXPANSION OF COLLABORATIVE AGREEMENT WITH ASTRAZENECA
About PharmaNetics : Press Releases : PHARMANETICS INITIATES COMPARATIVE STUDIES WITH ECT TEST
About PharmaNetics : Press Releases : PHARMANETICS FILES APPLICATION WITH FDA FOR HUMANITARIAN DEVICE EXEMPTION FOR ECARIN CLOTTING TIME (ECT) TEST
About PharmaNetics : Press Releases : PHARMANETICS REPORTS THIRD QUARTER RESULTS
About PharmaNetics : Press Releases : PHARMANETICS FILES 510(K) APPLICATION FOR NEW HEPARIN MANAGEMENT SYSTEM
About PharmaNetics : Press Releases : PHARMANETICS ANNOUNCES CESSATION OF DEVELOPMENT AGREEMENT WITH ELI LILLY
PHARMANETICS REPORTS SECOND QUARTER RESULTS --
About PharmaNetics : Press Releases : PHARMANETICS ANNOUNCES SALE OF COEUR LABORATORIES
About PharmaNetics : Press Releases : PHARMANETICS RECEIVES FDA CLEARANCE FOR TWO NEW PRODUCTS
PHARMANETICS REPORTS FIRST QUARTER RESULTS
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS FILES TWO 510(K) APPLICATIONS FOR THREE NEW PRODUCTS
About PharmaNetics : Press Releases : PHARMANETICS REPORTS FOURTH QUARTER AND 1998 YEAR-END RESULTS
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS ESTABLISHES HOLDING COMPANY; ANNOUNCES NEW BOARD MEMBER
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS SIGNS LETTER OF INTENT WITH ASTRA
CARDIOVASCULAR DIAGNOSTICS SIGNS LETTER OF INTENT WITH ASTRA
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS REPORTS THIRD QUARTER RESULTS
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS AND CHIRON DIAGNOSTICS SIGN GLOBAL DISTRIBUTION AGREEMENT
About PharmaNetics : Press Releases : CVDI COMPLETES PHASE II DEVELOPMENT OF TEST DESIGNED TO EVALUATE A NEW SEPSIS DRUG AND ENTERS CLINICAL FIELD TRIALS
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS, INC. REPORTS 1998 SECOND QUARTER RESULTS
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS, INC. REPORTS 1997 FOURTH QUARTER AND YEAR END RESULTS
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS TO RECEIVE SECOND MILESTONE PAYMENT FROM KNOLL FOR ANCROD STROKE TREATMENT TEST DEVELOPMENT
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS FILES 510 (K) APPLICATIONS FOR TWO THERAPEUTIC DIAGNOSTICS
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS RECEIVES $2.1 MILLION ORDER FROM KNOLL AG FOR ANALYZERS AND DIAGNOSTIC TEST CARDS
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS COMPLETES EQUIPMENT LOAN FINANCING WITH TRANSAMERICA BUSINESS CREDIT
About PharmaNetics : Press Releases : CARDIOVASCULAR DIAGNOSTICS, INC. PROVES FEASIBILITY FOR A TEST TO EVALUATE A NEW SEPSIS DRUG UNDER DEVELOPMENT BY ELI LILLY AND COMPANY
Links | |